Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release May 14 2026
Published 6d ago
3 min read

Press Release May 14 2026

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Darolutamide Tablets, 300 mg.".

View Attachment